ライフサイエンスコーパス: intent

1 uld be evaluated based on impact rather than intent.

2 herefore be considered to have a therapeutic intent.

3 gressive non-HL (ANHL) treated with curative intent.

4 ronal populations is used to decode movement intent.

5 en with the goal of determining an officer's intent.

6 d as unintentional, suicide, or undetermined intent.

7 ween open and MI esophagectomy with curative intent.

8 re in GIST patients treated with neoadjuvant intent.

9 diation and had been treated with a curative intent.

10 tivated by (i) self-interest or (ii) harmful intent.

11 ns in GIST patients treated with neoadjuvant intent.

12 new localized cancers treated with curative intent.

13 forcement agencies, regardless of individual intent.

14 UTUCs after nephroureterectomy with curative intent.

15 ns for cell-based therapeutics with curative intent.

16 astatic liver tumors with curative treatment intent.

17 est one for patients treated with palliative intent.

18 of an ampullary adenocarcinoma with curative intent.

19 ted with sexual arousal and without suicidal intent.

20 roducible, and expressive of style and human intent.

21 finitive consolidation therapy with curative intent.

22 15 (7%) patients who had undergone curative-intent ablation, surgery, or liver transplantation were

23 , NNT to benefit 46) and the neuroprotective intent analysis (RR 0.68, 95% CI 0.53 to 0.87, 3,988 bab

24 tabilizer does not require knowledge of user intent and can outperform supervised recalibration.

25 lity of neural decoding for both users' gait intent and continuous kinematics.

26 Humans are experts at recognizing intent and emotion from other people's body movements; h

27 ural interfaces are designed to decode motor intent and evoke sensory precepts in amputees.

28 nspecifics(1), but it is unclear whether the intent and neural encoding of these behaviours are simil

29 ndings suggest that people can recognize the intent and onset of motion by inferring its early warnin

30 ation and elaboration document describes the intent and rationale of each recommendation and discusse

31 Patients were treated with curative intent and received IC before definitive locoregional th

32 f others' intent, which we fitted to harmful intent and self-interest attributions made over 18 trial

33 ntial parameter estimates underlying harmful-intent and self-interest attributions.

34 se which is normally treated with palliative intent and systemic therapy.

35 exposure to a human intruder with uncertain intent and unpredictable loud noise.

36 ia whose cancer treatment is not curative in intent and whose hemoglobin has declined to < 10 g/dL.

37 tion, or, less commonly, both) with curative intent, and an Eastern Cooperative Oncology Group perfor

38 lifetime self-harm with and without suicidal intent at age 21 years).

39 he 42 NSCLC patients treated with palliative intent at Maria Sklodowska-Curie National Research Insti

40 he study and those not treated with curative intent at the time of bloodstream infection onset.

41 Paranoia had a positive effect on harmful intent attribution, for both fair and unfair dictators.

42 harmful intent attributions, making harmful intent attributions less reliant on prior interactions.

43 that induce greater probabilities of harmful intent attributions may also induce states of uncertaint

44 Overall, the magnitude of harmful intent attributions was directly related to their uncert

45 ationship between learning rates and harmful intent attributions, making harmful intent attributions

46 texts, and whether it is specific to harmful intent attributions, the live expression of paranoia.

47 cognitive parameters characterising harmful intent attributions.

48 The intent behind functional genomics experiments is not nec

49 tomy or gastrectomy for cancer with curative intent between 2011 and 2016 and were registered in the

50 Patients (2013-2018) treated with curative intent by open surgery were studied.

51 g response with (18)F-FDG PET after curative-intent chemoradiation for non-small cell lung cancer (NS

52 All patients were treated with curative-intent chemoradiotherapy (CRT).

53 ng disease-related (acute leukemia, curative intent chemotherapy), laboratory-related (platelet count

54 Locoregional therapy with curative intent (CLRT) followed by salvage liver transplantation

55 s were defined either as different treatment intent (curative, noncurative, or unable to determine) o

56 Demographic and intent data (1999-2013) were collected from the Centers

57 he outcome was unintentional or undetermined-intent death from prescription opioid overdose, identifi

58 for biomarker screening and rapid regulatory intent evaluation of targeted therapies and was the firs

59 nced stage, who were considered for curative-intent first-line therapy.

60 Randomisation was stratified by intent for ASCT at disease progression for the first ran

61 ed good acceptability, with greater purchase intent for both products when added with chia mucilage d

62 ment in time, our algorithm decodes movement intent for each available DOF into one of three classes:

63 gh patients undergo procedures with curative intent for early-stage hepatocellular carcinoma (HCC), u

64 transplantation (BMT) is used with curative intent for hematologic malignancies.

65 were able to undergo treatment with curative intent for local regrowth.

66 solid tumors, with therapeutic or palliative intents, for decades.

67 However, attributions of harmful intent have been poorly studied and mainly using artific

68 Analyses were stratified by intent (homicide, suicide, unintentional, or undetermine

69 al who underwent a gastrectomy with curative intent in a Dutch hospital were included in the analysis

70 The most common injury intent in both groups was assault (77.3% in Blacks vs in

71 overall and according to race/ethnicity and intent in fatal and nonfatal firearm injuries (FFIs and

72 e than low AQ subjects signaling cooperative intent in games with fixed strategy agents while spendin

73 68)Ga-PSMA PET/CT imaging affects management intent in patients with primary or recurrent prostate ca

74 Our intent in this study was to construct a gene co-expressi

75 superficially similar can express different intents in different contexts, but how this flexibility

76 Among 655 adults who received curative-intent induction or reinduction chemotherapy with 7 days

77 rimarily on the functional correlates of how intent information is neurally represented for moral jud

78 Much prior research asks how intent information is represented neurally, but little a

79 In peripheral nerves, recording movement intent is challenging because motor axons are only a sma

80 The intent is noble: minimize the number of participants ran

81 so, the writing group acknowledges that its intent is to assist other agencies charged with protecti

82 The intent is to evaluate the current data on mechanism of a

83 Whereas the intent is to improve quality, there has been increasing

84 Our intent is to provide a comprehensive overview of all wor

85 jury characteristics such as external cause, intent, location, and body part affected were reported f

86 were treated with complete CRS with curative intent (no residual nodules > 2.5 mm) at 19 French cente

87 stratification by country, age, radiotherapy intent, nodal status, and oestrogen receptor and HER-2 s

88 at a specialist cancer centre with curative-intent non-surgical treatment who underwent baseline and

89 A change in treatment intent occurred in 65.5% of subjects, disease stage chan

90 collaboration between investigators with the intent of achieving important innovations that would not

91 future machine learning approaches with the intent of augmenting traditional approaches with topolog

92 ay expedite therapeutic development with the intent of bringing novel therapies to this patient popul

93 a has led to questions about the loyalty and intent of Chinese American scientists.

94 a virus Makona via different routes with the intent of comparing RNA-Seq to a NanoString nCounter cod

95 es in an ex vivo cellular approach, with the intent of developing a therapy for patients with epiderm

96 hat hypofractionated radiotherapy failed the intent of either reducing physician-assessed late toxici

97 manipulate the shell permeability, with the intent of engineering BMC-based metabolic modules for ne

98 reers, in the Society's activities, with the intent of enhancing discovery in public health." As a fo

99 It requires understanding the intent of human drivers and adapting to their driving st

100 iterature on menopause and CVD risk with the intent of increasing awareness of the significant advers

101 ifiers, such as aromatic aldehydes, with the intent of increasing Hb affinity for O(2) with subsequen

102 Assault is the leading intent of injury in both Black and White children, but W

103 potension, Glasgow Coma Scale, mechanism and intent of injury, and Injury Severity Score.

104 With the intent of preserving nuclear architecture during long-te

105 ow one to merge multiple assemblies with the intent of producing a higher quality consensus assembly,

106 of guano from a cave in NW Romania with the intent of reconstructing past variation in ECE hydroclim

107 tion methods are standardly applied with the intent of reducing the non-biologically derived variabil

108 The intent of the following is to provoke the reader to refl

109 ormal training and depended on the intuitive intent of the user to activate movement and sensory feed

110 The intent of the Viewpoint is to summarize studies in rat O

111 The intent of this article is therefore to define prostate c

112 r IL-17A and infected with P. aeruginosa The intent of this design was to model (i) initiation of inf

113 The intent of this paper is to identify key concepts, papers

114 g experiments continue to improve, it is the intent of this study to provide and validate software fo

115 The intent of this study was to investigate if cerebrospinal

116 The intent of this tutorial is to provide a useful backgroun

117 icted to data from the 4 trials in which the intent of treatment was fetal neuroprotection, there was

118 s and setbacks of non-traditional approaches intent on circumventing bacterial drug resistance.

119 s of lung aspirates and postmortem specimens intent on identifying pneumococcal disease to studies of

120 itative behavior can occur without conscious intent or other higher-order cognitive process.

121 criteria consisted of suicidal or homicidal intent or psychosis.

122 proach for independent, multi-digit movement intent prediction based on multi-output, multi-class cla

123 We address the problem of user intent prediction from clickstream data of an e-commerce

124 both administered concurrently with curative intent radiotherapy in patients with LAHNSCC.

125 ence after radical prostatectomy or curative-intent radiotherapy were included in this prospective st

126 expand the population eligible for curative-intent radiotherapy, optimise and customise radiation do

127 Hepatoblastoma treatment with curative intent requires surgical resection, but only about a thi

128 ifferentiated PanNETs who underwent curative-intent resection at 9-institutions from 2000 to 2016 wer

129 patterns of first recurrence after curative-intent resection for pancreatic adenocarcinoma (PDAC).

130 ients who underwent NAT followed by curative-intent resection were matched by propensity score with p

131 gnosed from 2010 to 2015 undergoing curative intent resection were selected from the National Cancer

132 ears of age with PMBCL treated with curative intent rituximab-chemotherapy were identified.

133 l (CDFS) for patients who underwent curative intent surgery for adrenocortical carcinoma (ACC).

134 Consecutive patients undergoing curative-intent surgery for esophageal cancer from 2011 to 2017 i

135 Curative-intent surgery for potentially resectable PDAC is underu

136 ied patients with cancer undergoing curative-intent surgery from 2010 to 2014.

137 Although nearly one-quarter of curative-intent surgery patients were from high SED neighborhoods

138 of new persistent opioid use after curative-intent surgery, identify risk factors, and describe chan

139 ted surgical evaluation, receipt of curative-intent surgery, postoperative complications, receipt of

140 d use in cancer patients undergoing curative-intent surgery.

141 se among cancer patients undergoing curative-intent surgery.

142 t least one previous occasion) with suicidal intent than heterosexuals.

143 adiation treatment (62% change in management intent) than in patients undergoing primary staging (21%

144 danese at national and state levels with the intent that participants would become Ministry of Health

145 early-stage disease (presumably for curative intent), the outcomes were far worse (13.1, 18.9, 23.9%,

146 ce after primary PCa treatment with curative intent, three or fewer extracranial metastatic lesions o

147 with radiation therapy (RT), often with the intent to achieve complete and permanent tumor regressio

148 Intent to be vaccinated against COVID-19 was measured wi

149 Participants' intent to be vaccinated was explored before a vaccine wa

150 moral judgments rely both on a perpetrator's intent to cause harm, and also on the actual harm caused

151 monitoring for disease progression with the intent to cure) appears to be safe and has become the pr

152 care, in some cases leading to surgery with intent to cure.

153 With the intent to demonstrate that the charge of Z-type ligands

154 in AECs and to project unmet needs with the intent to enhance progress towards use of these faciliti

155 Candidate genes were selected with an intent to evenly sample the sequence homology space and

156 hich clinical treatment shifts from curative intent to extending survival.

157 linositol 3-kinase (PI3'K) pathways with the intent to induce radioiodine uptake for radioiodine trea

158 in those areas that are at risk; there is no intent to introduce the vaccine nationally.

159 In this review, it is not our intent to list each gene and locus and review their iden

160 dge, and practice gaps are analyzed with the intent to motivate prompt action.

161 oluntary control of movement, despite normal intent to move and an intact neural capacity for movemen

162 cations to undergo coronary angiography with intent to perform percutaneous coronary intervention.

163 tween December 2008 and August 2015 with the intent to perform TPVR.

164 geal cancer should be treated initially with intent to preserve the larynx by using endoscopic resect

165 apy and ten (83%) received chemotherapy with intent to proceed with HSCT.

166 unique pathogenesis of this virus; with the intent to rapidly develop vaccines and therapeutics.

167 ber 30, 2018, at 17 US institutions with the intent to receive SOC axi-cel.

168 Transition planning represents a serious intent to responsibly bring the world's largest global h

169 rticipants attributed equally strong harmful intent to the dictator in the observer role as in the re

170 randomized with 788 patients included in the intent to treat analysis (396 IPA and 392 chlorhexidine-

171 Analyses were intent to treat and per protocol.

172 major depressive disorder were enrolled with intent to treat in the open-label study; 36 completed tr

173 All analyses were done by intent to treat.

174 Data were analyzed as intent to treat.

175 ified Rankin Scale score of 0-2, analysed by intent to treat; non-inferiority was established with a

176 itivity undergoing coronary angiography with intent to undergo percutaneous coronary intervention.

177 All participants attributed more harmful intent to unfair as opposed to fair dictators.

178 ilar among those starting both regimens (ie, intent-to treat hazard ratio [HR], 0.96 [95% confidence

179 arly diagnosis of HGSC and STIC, followed by intent-to-cure surgery.

180 Nurse outcomes were job satisfaction and intent-to-stay.

181 Intent-to-treat (ITT) analysis within the RCT showed WOT

182 longer with rucaparib versus placebo in the intent-to-treat (ITT) population (375 randomly assigned

183 r the first dose of either study drug in the intent-to-treat (ITT) population (all randomized patient

184 fter the first dose of the study drug in the intent-to-treat (ITT) population (noninferiority margin,

185 8-72 hours after treatment initiation in the intent-to-treat (ITT) population and the European Medici

186 esponse rate of 33.4% after induction in the intent-to-treat (ITT) population, which was similar in t

187 On intent-to-treat (ITT), the sCR rate reached 76%.

188 In the microbiologic modified intent-to-treat (m-MITT) population, ZTI-01 met the prim

189 with axi-cel and were included in a modified intent-to-treat (mITT) analysis.

190 s day 28 all-cause mortality in the modified intent-to-treat (MITT) population (patients who received

191 Primary analysis was modified Intent-to-Treat (mITT), responder analysis using a previ

192 nfection type) in the modified microbiologic intent-to-treat (mMITT) population (qualifying baseline

193 r 1-year fixed-duration (n = 125) treatment (intent-to-treat [ITT] population).

194 Overall, 753 subjects were randomized (intent-to-treat [ITT] population; PVP-I/DEX [n = 324]; P

195 ho received >=1 dose of study drug (modified-intent-to-treat [mITT] population).

196 nts were randomly assigned and considered in intent-to-treat analyses (103 patients in arm A and 101

197 Using intent-to-treat analyses (N=200), both prolonged exposur

198 Modified intent-to-treat analyses indicated a significant interac

199 We did mixed-effects, intent-to-treat analyses to examine treatment effects on

200 Linear mixed-model intent-to-treat analyses were used to identify brain reg

201 In intent-to-treat analyses, retention (>=1 follow-up) was

202 and secondary outcomes between groups using intent-to-treat analyses.

203 111 placebo) in VISUAL-2 were studied using intent-to-treat analyses.

204 arch 2018; 189 patients were included in the intent-to-treat analysis (mean age, 34.0 years; 77.8% fe

205 Intent-to-treat analysis did show an improvement in the

206 This intent-to-treat analysis included 721 children ages 2 to

207 Comparison of ipi3 versus HDI used an intent-to-treat analysis of concurrently randomly assign

208 An intent-to-treat analysis of overall survival (ITT-OS) of

209 s who received treatment were included in an intent-to-treat analysis of the response rate.

210 In the intent-to-treat analysis set, the OR was 81.3% in the de

211 ional hazards models were used in a modified intent-to-treat analysis to compare hazard rates among t

212 The primary outcome from the intent-to-treat analysis was change from baseline to wee

213 Intent-to-treat analysis was used.

214 In an intent-to-treat analysis with a median follow-up of 64 m

215 compared with 10.7% in the midazolam group (intent-to-treat analysis).

216 In the intent-to-treat analysis, 19 of 22 participants (86.4%)

217 In the intent-to-treat analysis, 82 of 345 patients with the as

218 Based on intent-to-treat analysis, endoscopic remission (SES-CD s

219 By intent-to-treat analysis, sustained virologic response a

220 In intent-to-treat analysis, there was a trend for prebioti

221 vents to infusion were evaluated by using an intent-to-treat analysis.

222 25 women screened, 650 were eligible for the intent-to-treat analysis.

223 90/29,620), and 78.1% (29,090/37,256) in the intent-to-treat analysis.

224 ng mammogram by 12 months as evaluated in an intent-to-treat analysis.

225 1.15; 95% CI, 0.83 to 1.59; P = .41) in the intent-to-treat analysis.

226 18 months post-random assignment based on an intent-to-treat analysis.

227 s]; 45% women) were included in the modified intent-to-treat analysis.

228 ol analysis and 78.1% (29 090/37 256) in the intent-to-treat analysis.

229 duction and were considered MRD positive for intent-to-treat analysis.

230 Using both intent-to-treat and as-treated approaches, we performed

231 In both the intent-to-treat and completer samples, GSK561679 failed

232 Analyses were done in intent-to-treat and evaluable populations.

233 Intent-to-treat and on-treatment analyses were performed

234 ed variables, and present both observational intent-to-treat and per-protocol estimates.

235 statistically different between groups on an intent-to-treat basis (p = 0.25).

236 point was objective response, analyzed on an intent-to-treat basis per the International Neuroblastom

237 location (distal/proximal), and stage, on an intent-to-treat basis.

238 pic surgery, and robotic surgery (RS)] on an intent-to-treat basis.

239 lticenter, double-blind, placebo-controlled, intent-to-treat clinical trial.

240 Observational intent-to-treat cohort analysis using the Veterans Affai

241 -year survival were 20.7 months/17.9% in the intent-to-treat cohort and 23.2 months/21.2% in the MCR

242 ave differential response trajectories using intent-to-treat data from both trials (n = 4706) along w

243 and Drug Administration Snapshot algorithm (intent-to-treat exposed population) at Week 48.

244 The overall intent-to-treat minimal residual disease-negative (MRD(-

245 In an intent-to-treat model, multivariate analysis demonstrate

246 Forty-six (92%) of the initial study's intent-to-treat participants were included.

247 Among 185 randomly assigned intent-to-treat patients at week 12, a dose-response rel

248 RD) negativity (10-5 threshold) rates in the intent-to-treat population (51.0% vs 20.4%; P < .0001).

249 In the intent-to-treat population (n = 1,810) at Week 24 for tr

250 in favor of everolimus by 11.8 mL/min in the intent-to-treat population (P = 0.004) and 17.2 mL/min i

251 ts enrolled, 183 were in the microbiological intent-to-treat population (~21% IC).

252 At Week 32 (intent-to-treat population [n = 145]), the least squares

253 groups on the modified Rankin scale for the intent-to-treat population at day 90 (mean difference, 0

254 responses) after each treatment cycle in the intent-to-treat population every 4 weeks starting at wee

255 eened, and 126 were randomized; the modified intent-to-treat population included 121 patients (51 wom

256 The intent-to-treat population included 225 participants, of

257 The intent-to-treat population included 929 patients (creati

258 ry efficacy analyses were performed with the intent-to-treat population including all data through da

259 rom start of therapy) in the microbiological intent-to-treat population using a NI margin of 12.5%.

260 rative re-evaluation of the underlying RCT's intent-to-treat population was performed for the entire

261 t was preceded by a 30-day washout (modified intent-to-treat population).

262 In the intent-to-treat population, mean TNSS score for the subl

263 For the microbiological intent-to-treat population, the rates of clinical cure a

264 In a modified intent-to-treat population, there were no differences be

265 d for each active dose level versus placebo (intent-to-treat population, two-sided alpha of .05).

266 In the intent-to-treat population, we observed similar pCR rate

267 core for ADS-5102 vs placebo in the modified intent-to-treat population.

268 near mixed-effects modeling in line with the intent-to-treat principle was used to examine how baseli

269 ssion rates were similar for the two groups (intent-to-treat rates, 41.6% for the CBT group and 42.9%

270 Using intent-to-treat resident-level analysis with Cox proport

271 alysis assessed outcome at week 24 among the intent-to-treat sample, with responders defined as havin

272 This intent-to-treat study was a randomized clinical trial pe

273 In this multicenter intent-to-treat study, DAA therapy was not found to be a

274 At day 71, the proportion of intent-to-treat subjects achieving 50% or greater improv

275 In a non-intent-to-treat trial, 42 patients with MF and normal le

276 Overall response rate (intent-to-treat) was 65%, with 49% complete response (CR

277 independent central review, was analysed by intent-to-treat.

278 Analyses were intent-to-treat.

279 Sixty-five patients were implanted (intent-to-treat/safety population).

280 virologic response (HIV-1 RNA <50 copies/mL; intent-to-treat; US Food and Drug Administration [FDA] s

281 virologic response (HIV-1 RNA <50 copies/mL; intent-to-treat; US Food and Drug Administration [FDA] s

282 er included all patients undergoing curative-intent total gastrectomy for gastric adenocarcinoma betw

283 In total, 120 patients underwent curative-intent total gastrectomy for stage I through III gastric

284 tripled normalized costs following curative-intent total gastrectomy.

285 l residual disease monitoring after curative intent treatment for earlier detection of disease recurr

286 cell lung cancer who have undergone curative-intent treatment.

287 ifetime self-harm act regardless of suicidal intent) using data from the UK Biobank (n > 156,000).

288 On multivariate analysis, suicide intent was found to be an independent predictor of morta

289 Firearm injury intent was not specified because of misclassification co

290 Our intent was to quantify how changes in land use and ponds

291 exocrine pancreatic malignancy with curative intent were identified from a prospective database.

292 oing upfront surgical resection for curative intent were identified in the National Cancer Data Base

293 from 2000 to 2012 and treated with curative intent were included from the United States and Sweden (

294 ant chemotherapy after surgery with curative intent were included in our double-blind phase III multi

295 biliary tract cancer resected with curative intent were randomly assigned to the capecitabine group

296 tion or liver transplantation, with curative intent, were used.

297 structed a 'Bayesian brain' model of others' intent, which we fitted to harmful intent and self-inter

298 er (NSCLC) who undergo surgery with curative intent will relapse within 5 years(1,2).

299 nts treated for a stage II OCC in a curative intent (with primary tumor resection) between January 20

300 ligible for surgical resection with curative intent, with 5-year overall survival of less than 10% fo